List of NewLink Genetics patents

List of NewLink Genetics patents

List of Johnson & Johnson patents

List of Heidelberg Pharma patents

List of Abraxis BioScience patents

List of Transcend Information patents

Investment funds in California

Patents where

Current Assignee

Name

is

NewLink Genetics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9617272 Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization	Patent 9617272 was granted and assigned to NewLink Genetics on April, 2017 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9617272	April 11, 2017
	‌ US Patent 9732035 Salts and prodrugs of 1-methyl-D-tryptophan	Patent 9732035 was granted and assigned to NewLink Genetics on August, 2017 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9732035	August 15, 2017
	‌ US Patent 10233190 IDO inhibitors	Patent 10233190 was granted and assigned to NewLink Genetics on March, 2019 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	10233190	March 19, 2019
	‌ US Patent 10207990 Salts and prodrugs of 1-methyl-D-tryptophan	Patent 10207990 was granted and assigned to NewLink Genetics on February, 2019 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	10207990	February 19, 2019
	‌ US Patent 8722720 Imidazole derivatives as IDO inhibitors	Patent 8722720 was granted and assigned to NewLink Genetics on May, 2014 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	8722720	May 13, 2014
	‌ US Patent 7998486 Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes	Patent 7998486 was granted and assigned to NewLink Genetics on August, 2011 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	7998486	August 16, 2011
	‌ US Patent 9260434 Fused imidazole derivatives useful as IDO inhibitors	Patent 9260434 was granted and assigned to NewLink Genetics on February, 2016 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9260434	February 16, 2016
	‌ US Patent 9388191 Fused imidazole derivatives useful as IDO inhibitors	Patent 9388191 was granted and assigned to NewLink Genetics on July, 2016 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9388191	July 12, 2016
	‌ US Patent 9512158 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes	Patent 9512158 was granted and assigned to NewLink Genetics on December, 2016 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9512158	December 6, 2016
	‌ US Patent 9090643 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes	Patent 9090643 was granted and assigned to NewLink Genetics on July, 2015 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9090643	July 28, 2015
	‌ US Patent 8916169 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes	Patent 8916169 was granted and assigned to NewLink Genetics on December, 2014 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	8916169	December 23, 2014
	‌ US Patent 9981973 Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization	Patent 9981973 was granted and assigned to NewLink Genetics on May, 2018 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9981973	May 29, 2018
	‌ US Patent 8357777 Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes	Patent 8357777 was granted and assigned to NewLink Genetics on January, 2013 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	8357777	January 22, 2013
	‌ US Patent 9850248 IDO inhibitors	Patent 9850248 was granted and assigned to NewLink Genetics on December, 2017 by the United States Patent and Trademark Office.	NewLink Genetics	NewLink Genetics		United States Patent and Trademark Office	9850248	December 26, 2017
	‌ US Patent 9174942 IDO inhibitors	Patent 9174942 was granted and assigned to NewLink Genetics on November, 2015 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	9174942	November 3, 2015
	‌ US Patent 10047066 IDO inhibitors	Patent 10047066 was granted and assigned to NewLink Genetics on August, 2018 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	10047066	August 14, 2018
	‌ US Patent 7078179 Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase	Patent 7078179 was granted and assigned to NewLink Genetics on July, 2006 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	7078179	July 18, 2006
	‌ US Patent 6897020 Methods and compositions for elucidating relative protein expression levels in cells	Patent 6897020 was granted and assigned to NewLink Genetics on May, 2005 by the United States Patent and Trademark Office.		NewLink Genetics		United States Patent and Trademark Office	6897020	May 24, 2005

18 results

0 selected

18 results

0 selected